Sign in

CIK 0001438533

  • Large accelerated filer

Travere Therapeutics, Inc.

Sign in to watch
Ticker
TVTX
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
CA
Entity type
Operating
EIN
262383102
Phone
+1 888-969-7879
Business address
3611 VALLEY CENTRE DR, SUITE 300, SAN DIEGO, CA, 92130
Former names
Retrophin, Inc., Desert Gateway, Inc.
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$79,495,607
in 10 filings, $79.5M under 10b5-1 plans

Net −$79,495,607. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Reading 20 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2014-11-17 Clague Laura Chief Financial Officer Grant or award · Employee stock option (right to buy) +100,000 100,000
2014-11-14 Shkreli Martin Fmr Officer Dir 10% Sharehldr Sale −100,000 $10.23 $1.0M 2,837,168
2014-11-06 Richardson Steven Gary Director Grant or award +20,000 122,065
2014-11-06 Richardson Steven Gary Director Grant or award · Employee Stock Option (Right to Buy) +25,000 25,000
2014-11-06 Golding Cornelius E Director Grant or award +20,000 23,000
2014-11-06 Golding Cornelius E Director Grant or award · Employee Stock Option (Right to Buy) +25,000 25,000
2014-11-06 ASELAGE STEVE Chief Executive Officer Grant or award +100,000 361,756
2014-11-06 ASELAGE STEVE Chief Executive Officer Grant or award · Employee Stock Option (Right to Buy) +300,000 300,000
2014-10-08 Meckler Jeffrey A Director Grant or award +20,000 20,000
2014-10-08 Meckler Jeffrey A Director Grant or award · Stock Option (Right to Buy) +40,000 40,000
2014-10-08 LYONS GARY A Director Grant or award +20,000 20,000
2014-10-08 LYONS GARY A Director Grant or award · Stock Option (Right to Buy) +40,000 40,000
2014-10-02 Shkreli Martin Chief Executive Officer Other acquisition +332,980 2,995,148
2014-10-01 Shkreli Martin Chief Executive Officer Purchase +25,000 $8.11 $203K 2,962,168
2014-10-01 Shkreli Martin Chief Executive Officer Sale −300,000 $0.01 $3K 2,662,168
2014-09-30 Shkreli Martin Chief Executive Officer Purchase +4,000 $9.42 $38K 2,937,168
2014-09-22 Shkreli Martin Chief Executive Officer Purchase +35,000 $10.82 $379K 2,933,168
2014-09-19 Shkreli Martin Chief Executive Officer Purchase +18,000 $11.78 $212K 2,898,168
2014-09-17 Shkreli Martin Chief Executive Officer Purchase +6,000 $11.46 $69K 2,880,168
2014-09-16 Shkreli Martin Chief Executive Officer Purchase +7,500 $10.69 $80K 2,874,168

Page 57 of 59 · 1,174 trades